耐火性瘤和神经退行性囊细胞瘤用动脉内化疗治疗
Alexander Ramos1,2, Andrew L A Garton2, Jared Knopman2
1Department of Neurological Surgery, Columbia University Irving Medical Center, New York, NY.
Neurology(R) neuroimmunology & neuroinflammation
|October 23, 2025
概括
动脉内梅尔法兰化疗为涉及神经系统,眼睛和头部/部的细胞瘤提供了安全有效的治疗方法,改善了放射和功能结果. 这种方法对耐药性疾病或对其他疗法不耐受的患者来说是有希望的.
科学领域:
- 血液学 血液学 血液学
- 干预性放射学 干预性放射学
- 在瘤学瘤学.
背景情况:
- 胰腺细胞瘤是一种血液形成障碍的一组,可以导致显著的神经功能障碍.
- 虽然有针对性的疗法显示出希望,但一些患者经历了不耐受性或具有影响神经,眼睛或头部 (NOHN) 结构的耐火性疾病.
- 动脉内化疗是各种瘤的潜在治疗方法,但其在细胞瘤亚型中的应用需要检查.
研究的目的:
- 评估对涉及NOHN结构的囊细胞瘤的动脉内梅尔法兰输液的安全性和有效性.
- 评估使用这种新疗法治疗的患者的放射性和功能性结果.
- 为了确定治疗后后续疾病进展的速度.
主要方法:
- 生物检测证明了影响NOHN结构的囊细胞瘤的患者通过血管造影接受了选择性静脉内梅尔法兰输液.
- 治疗后进行了放射性评估 (PET/CT,CT,MRI) 和功能评估 (视力,言语,平衡).
- 系统地记录了治疗反应,进展和并发症.
主要成果:
- 在14名可评估的瘤病患者中,71%的患者获得了部分或完全的放射性反应,21%的患者随后出现了进展.
- 13名可功能评估的患者中有12名 (92%),包括神经退行性细胞瘤患者,表现出功能改善.
- 没有发生过程内并发症;三名患者需要住院治疗,其中一名患者对梅尔法兰过敏反应.
结论:
- 动脉内梅尔法兰是一种安全有效的治疗瘤和神经退行性细胞瘤,从而改善神经功能.
- 这种模式可能为耐火性NOHN囊细胞瘤和神经退行性形式提供一种改变实践的选择.
- 需要进一步的研究来确定最佳候选患者,并探索其在其他影响这些区域的癌症中的有效性.
更多相关视频
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
4.1K
09:08Author Spotlight: Advancing Glioblastoma Treatment Through Intraarterial Delivery Strategies for Oncolytic Viruses and MicroRNAs
Published on: March 15, 2024
2.8K
相关概念视频
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...